Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Moretti

Showing results (181-190 of 479) with videos related to

Pageof 48
Sort By:
The Journal of Clinical Endocrinology and Metabolism|August 6, 2002
Locally expressed LHRH receptors mediate the oncostatic and antimetastatic activity of LHRH agonists on melanoma cellsRoberta M Moretti, Marina Montagnani Marelli, Johan C Van Groeninghen, et al.
Journal of Neuroimmunology|January 8, 2000
Antibodies against neuronal nicotinic receptor subtypes in neurological disordersB Balestra, M Moretti, R Longhi, et al.
Steroids|April 1, 1996
Growth factors in steroid-responsive prostatic tumor cellsD Dondi, R M Moretti, M M Marelli, et al.
International Journal of Oncology|December 5, 2006
Gonadotropin-releasing hormone agonists reduce the migratory and the invasive behavior of androgen-independent prostate cancer cells by interfering with the activity of IGF-IMarina Montagnani Marelli, Roberta M Moretti, Stefania Mai, et al.
International Journal of Oncology|October 30, 2014
Oxime bond-linked daunorubicin-GnRH-III bioconjugates exert antitumor activity in castration-resistant prostate cancer cells via the type I GnRH receptorMarina Montagnani Marelli, Marilena Manea, Roberta M Moretti, et al.
Endocrinology|January 14, 1999
Luteinizing hormone-releasing hormone agonists interfere with the mitogenic activity of the insulin-like growth factor system in androgen-independent prostate cancer cellsM M Marelli, R M Moretti, D Dondi, et al.
Rivista Di Emoterapia Ed Immunoematologia|January 1, 1985
[Cryopreservation of erythrocytes: current status]R Reverberi, L Ferrari, M Moretti, et al.
Rivista Di Emoterapia Ed Immunoematologia|January 1, 1985
[Preparation of young erythrocytes for transfusion. Results of some experimental protocols in neocytopheresis]R Reverberi, L Ferrari, R Ferrari, et al.
International Journal of Cancer|August 12, 2004
Activation of the orphan nuclear receptor RORalpha counteracts the proliferative effect of fatty acids on prostate cancer cells: crucial role of 5-lipoxygenaseRoberta M Moretti, Marina Montagnani Marelli, Angelo Sala, et al.
International Journal of Oncology|February 9, 2006
Insulin-like growth factor-I promotes migration in human androgen-independent prostate cancer cells via the alphavbeta3 integrin and PI3-K/Akt signalingMarina Montagnani Marelli, Roberta M Moretti, Patrizia Procacci, et al.
Pageof 48

Showing results (181-190 of 479) with videos related to

Sort By:
Pageof 48
The Journal of Clinical Endocrinology and Metabolism|August 6, 2002
Locally expressed LHRH receptors mediate the oncostatic and antimetastatic activity of LHRH agonists on melanoma cellsRoberta M Moretti, Marina Montagnani Marelli, Johan C Van Groeninghen, et al.
Journal of Neuroimmunology|January 8, 2000
Antibodies against neuronal nicotinic receptor subtypes in neurological disordersB Balestra, M Moretti, R Longhi, et al.
Steroids|April 1, 1996
Growth factors in steroid-responsive prostatic tumor cellsD Dondi, R M Moretti, M M Marelli, et al.
International Journal of Oncology|December 5, 2006
Gonadotropin-releasing hormone agonists reduce the migratory and the invasive behavior of androgen-independent prostate cancer cells by interfering with the activity of IGF-IMarina Montagnani Marelli, Roberta M Moretti, Stefania Mai, et al.
International Journal of Oncology|October 30, 2014
Oxime bond-linked daunorubicin-GnRH-III bioconjugates exert antitumor activity in castration-resistant prostate cancer cells via the type I GnRH receptorMarina Montagnani Marelli, Marilena Manea, Roberta M Moretti, et al.
Endocrinology|January 14, 1999
Luteinizing hormone-releasing hormone agonists interfere with the mitogenic activity of the insulin-like growth factor system in androgen-independent prostate cancer cellsM M Marelli, R M Moretti, D Dondi, et al.
Rivista Di Emoterapia Ed Immunoematologia|January 1, 1985
[Cryopreservation of erythrocytes: current status]R Reverberi, L Ferrari, M Moretti, et al.
Rivista Di Emoterapia Ed Immunoematologia|January 1, 1985
[Preparation of young erythrocytes for transfusion. Results of some experimental protocols in neocytopheresis]R Reverberi, L Ferrari, R Ferrari, et al.
International Journal of Cancer|August 12, 2004
Activation of the orphan nuclear receptor RORalpha counteracts the proliferative effect of fatty acids on prostate cancer cells: crucial role of 5-lipoxygenaseRoberta M Moretti, Marina Montagnani Marelli, Angelo Sala, et al.
International Journal of Oncology|February 9, 2006
Insulin-like growth factor-I promotes migration in human androgen-independent prostate cancer cells via the alphavbeta3 integrin and PI3-K/Akt signalingMarina Montagnani Marelli, Roberta M Moretti, Patrizia Procacci, et al.
Pageof 48